Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03909605
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.73 | |
CCL | N~6~-[(CYCLOPENTYLOXY)CARBONYL]- D-LYSINE | A | 2Q7G | 0.76 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B80 | 0.75 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B7V | 0.75 | |
59A | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCINE | A | 2DC8 | 0.71 | |
HLU | BETA-HYDROXYLEUCINE | A | 1ROV | 0.7 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.79 | |
MNL | 4,N-DIMETHYLNORLEUCINE | C | 1CWC | 0.7 | |
N10 | O-[(HEXYLAMINO)CARBONYL]-L-SERINE | A,B,C,D,E,F, G,H | 2Q0S | 0.71 | |
TMD | (6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N- DIMETHYL-THREONINE | C | 1CWK | 0.77 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.7 | |
LBY | N~6~-(TERT-BUTOXYCARBONYL)-L-LYSINE | A | 2ZIN | 0.78 | |
HC5 | (R)-3-CARBOXY-2-(HEXANOYLOXY)-N,N,N- TRIMETHYLPROPAN-1-AMINIUM | A,B | 2H3W | 0.71 | |
CHS | 4-AMINO-5-CYCLOHEXYL-3-HYDROXY- PENTANOIC ACID | I | 1E80 | 0.71 | |
CHS | 4-AMINO-5-CYCLOHEXYL-3-HYDROXY- PENTANOIC ACID | I | 1EED | 0.71 | |
CHS | 4-AMINO-5-CYCLOHEXYL-3-HYDROXY- PENTANOIC ACID | I | 2ER0 | 0.71 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.71 | |
DH9 | (2S,3S,5S)-5-[(N-FORMYL-L-LEUCYL)OXY]- 2-HEXYL-3-HYDROXYHEXADECANOIC ACID | A,B | 2PX6 | 0.74 | |
0AG | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.8 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.75 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.75 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.75 | |
LTA | 4,8-DIAMINO-3-HYDROXY-OCTANOIC ACID ETHYL ESTER | E,I | 1APT | 0.7 | |
DFI | 2,2-DIFLUOROSTATINE | E,I | 1APW | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.75 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.75 | |
STA | STATINE | E | 1EPP | 0.77 | |
STA | STATINE | I | 1XN3 | 0.77 | |
STA | STATINE | A,B,I,J | 2FIV | 0.77 | |
STA | STATINE | A,B,C,D | 1QS8 | 0.77 | |
STA | STATINE | A,B | 2RMP | 0.77 | |
STA | STATINE | E,I | 1APU | 0.77 | |
STA | STATINE | A,I | 1GVU | 0.77 | |
STA | STATINE | I | 3ER5 | 0.77 | |
STA | STATINE | I | 2ER9 | 0.77 | |
STA | STATINE | E,I | 4ER2 | 0.77 | |
STA | STATINE | A,C,I,J,K | 2B7F | 0.77 | |
STA | STATINE | A,B,C | 5HVP | 0.77 | |
STA | STATINE | A,I | 1GVV | 0.77 | |
STA | STATINE | A,I | 1WKR | 0.77 | |
STA | STATINE | I | 5APR | 0.77 | |
STA | STATINE | I | 1PSO | 0.77 | |
STA | STATINE | I | 6APR | 0.77 | |
STA | STATINE | A | 1FQ5 | 0.77 | |
STA | STATINE | A,I | 3FNT | 0.77 | |
STA | STATINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P | 3FV3 | 0.77 | |
STA | STATINE | A,B,C,D,I,J | 1LYB | 0.77 | |
STA | STATINE | B | 1FIV | 0.77 | |
STA | STATINE | I | 4APR | 0.77 |